Clinicoradiological Profile of Patients with Hydropneumothorax: A Prospective Study of a Hospital Population in Northern India

Singh, Sudhir; Yadav, Pratibha; Jatav, Bhupendra; Tiwari, Kamlesh Kumar

doi:10.4103/ijrc.ijrc_87_20

Cited by 3 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other studies have also found breathlessness to be the most common symptom of hydropneumothorax[ 10 ] and pneumothorax. [ 11 ] Fever, chest pain and weight loss are other major complaints in patients of hydropneumothorax due to tubercular aetiology[ 12 ] and were also found in our patients. National guidelines for diagnosis and treatment[ 9 ] should be used, in all cases of pleural effusion of tubercular aetiology, including microbiological confirmation and universal drug sensitivity testing by genotypic method of pleural fluid for CB-NAAT.…”

Section: Discussionsupporting

confidence: 68%

Does Serratiopeptidase prevent thoracic surgery in patients of hydropneumothorax of tubercular aetiology?

Shukla,

Agarwal

2023

Lung India

View full text Add to dashboard Cite

Background: Tubercular hydropneumothorax is commonly seen in Indian hospitals. Anti-tuberculosis drugs and intercostal drainage tube (ICD) insertion are the mainstays of treatment. But many patients have to be referred to thoracic surgery for surgical management. This study aims to evaluate the role of serratiopeptidase in successful resolution of tubercular hydropneumothorax and avoidance of thoracic surgery. Methods: We conducted a retrospective observational cohort study on 28 patients that were admitted to extrapulmonary TB ward of our hospital. All patients were given anti-TB drugs according to national guidelines and underwent ICD tube insertion. Out of 28 patients recruited, 19 suffering severe chest pain received serratiopeptidase containing analgesic tablets and nine patients of the control group not having severe chest pain received non-serratiopeptidase containing analgesic tablets. Both groups were compared on the basis of successful ICD tube removal. The results were analysed using Chi-square statistic with Yates correction. Results: Of the 19 patients in the intervention group who received serratiopeptidase, 16 had successful recovery while three had to undergo thoracic surgery. Of the nine patients in the comparison group, only one had a successful recovery while the other eight had to be referred to thoracic surgery with ICD tube in situ. The outcome showed a statistically significant difference between the two groups, in terms of ICD tube removal and avoidance of thoracic surgery, with a P value of < 0.001. Conclusion: We conclude that the addition of serratiopeptidase to anti-tubercular drugs regimen can lead to better clinical outcomes and avoidance of thoracic surgery, in patients of tubercular hydropneumothorax.

show abstract

Section: Discussionsupporting

confidence: 68%

Does Serratiopeptidase prevent thoracic surgery in patients of hydropneumothorax of tubercular aetiology?

Shukla,

Agarwal

2023

Lung India

View full text Add to dashboard Cite

show abstract

“…et al in which the mean age of the patients was 44.2 years (SD =16.3), and 80.7% of patients were males. Our study is in(12) …”

mentioning

confidence: 99%

Clinical profile, diagnosis and outcome of patients of Pneumothorax and Hydropneumothorax: Observational study

Sanpurkar,

Barade

2023

BVMJ

View full text Add to dashboard Cite

Introduction: Pneumothorax and hydropneumothorax are among two important clinical conditions that come across in pulmonary medicine. Data regarding the clinical profile, diagnosis, and outcome of pneumothorax and hydropneumothorax are limited. This study was done to know more about these two important respiratory entities. Aim: To describe clinical profile, diagnosis with reference to pathology, and outcome of hydropneumothorax/pneumothorax. Materials and Methods: It was a hospital-based prospective observational study. The patients included were the diagnosed cases of pneumothorax and hydropneumothorax during the period June 2016 to November 2018. Clinical symptoms and a thorough clinical history were asked, followed by a detailed clinical examination. Chest X-rays were done for confirmation of clinical diagnosis. Whenever applicable, blood, sputum, and pleural fluid investigations were advised. As a treatment, an Intercostal Drainage (ICD) tube was inserted and kept until the clinical and radiological recovery of the patient. Results: Hundred patients were studied. Most of the patients presented with breathlessness, cough, chest pain, loss of appetite, and fever. About 92% of patients with pneumothorax had breathlessness, while about 94% of pneumothorax had breathlessness. About 43% of cases of pneumothorax and 65% of cases of hydropneumothorax were due to tuberculosis. We inserted an ICD tube in all the patients. The mean duration of the requirement of an ICD tube was 11.08 days (SD=8.60) in cases of pneumothorax and 18.6 days (SD=10.16) in cases of hydropneumothorax. Conclusion: The most common clinical feature is breathlessness. Tuberculosis was the most common etiology. ICD was required for a longer duration of time for hydropneumothorax compared to that for pneumothorax.

show abstract

Respiratory challenges in huntington\'s disease: The emergence of hydropneumothorax

Meghana,

B S,

B S

et al. 2024

IJIRM

View full text Add to dashboard Cite

Hydropneumothorax, an abnormal collection of fluid and air in the cavity of the pleural space, typically arises by medical interventions such as fluid aspiration or intercostal tube infections. Hydropneumothorax due to tuberculosis is an unusual presentation characterized by the respiratory symptoms such as shortness of breath, cough, fever, in addition to extra pulmonary symptoms. There has been a scanty data on patients presenting with hydropneumothorax due to tuberculosis as its occurrence is relatively rare. Here we present a case of 30-year-old Asian man with Huntington's disease arrived to emergency department with complaints of severe breathing issues, discomfort in his chest, and decreased response. During chest auscultation, a distinct Hippocratic succussion splash was observed which was likely attributed to fluid movement in the right lung. A CT scan indicated considerable fluid accumulations with mediastinal shift and fibro-atelectatic bands in the right lung for which he was diagnosed with hydropneumothorax. Followed which he was put on mechanical respiration and an intercostal drainage tube. Micrococcus were detected after a microbiological investigation. Sputum analysis, tuberculin skin test and PCR analysis revealed the presence of acid-fast bacillus. He then received anti TB drugs along with intravenous piperacillin-tazobactam, inotropic support, nebulization drugs. However, the patient eventually developed sepsis due to the wide spread of the infection.

show abstract

Clinicoradiological Profile of Patients with Hydropneumothorax: A Prospective Study of a Hospital Population in Northern India

Cited by 3 publications

References 10 publications

Does Serratiopeptidase prevent thoracic surgery in patients of hydropneumothorax of tubercular aetiology?

Does Serratiopeptidase prevent thoracic surgery in patients of hydropneumothorax of tubercular aetiology?

Clinical profile, diagnosis and outcome of patients of Pneumothorax and Hydropneumothorax: Observational study

Respiratory challenges in huntington\'s disease: The emergence of hydropneumothorax

Contact Info

Product

Resources

About